载VEGF肝素化HA-TCP明胶支架的理化性能及其生物学效应初步评价

Abstract
Figure/Table
References
Related Citation (15)

Download: PDF (3366 KB) HTML (0 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To investigate the structure and physicochemical properties of vascular endothelial growth factor (VEGF) heparinized hydroxyapatite-tricalcium phosphate (HA-TCP) gelatin scaffold, and to evaluate its effect on the differentiation of bone marrow mesenchymal stem cells (BMSC).Methods Heparin was combined with HA-TCP gelatin scaffold to detect the physical structure and mechanical properties of the scaffold. To preliminarily evaluate the performance of heparinized HA-TCP gelatin scaffolds with different heparin concentrations, water absorption, VEGF loading, antibacterial ability and bone marrow mesenchymal stem cell (BMSC) growth were analyzed.Results The VEGF-loaded heparinized HA-TCP gelatin scaffold was pale yellow, with abundant pores (from 100 to 400μm), the specific surface area was 1.01±0.06 m²/g, the average mesoporous size was 25.96 nm, the elastic modulus was 0.93 MPa, and the maximum compressive strength was 2.40 MPa. There was no significant difference in the water absorption rate of HA-TCP gelatin scaffold among the three groups. The heparinized scaffold group had better VEGF binding and sustained release ability than the blank scaffold group (P<0.05), and the high heparin group could maintain the VEGF activity concentration and antibacterial ability longer than the low heparin group (P<0.05). BMSCs were distributed in sheets and islands on the scaffold. The cell proliferation activity of the heparinized scaffold group was significantly stronger than that of the blank group (P<0.05), and more calcium nodules were generated.Conclusions VEGF-loaded heparinized HA-TCP gelatin scaffold is characterized by good physical and chemical properties, and heparinization can improve the VEGF loading and releasing ability, bacteriostatic ability, and promote the proliferation and osteogenic differentiation of BMSCs, which is a promising bone tissue engineering material.

Key words： VEGF HA-TCP heparin tissue engineering

Received: 08 November 2021

ZTFLH:

R68

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	CHEN Yitian
	CHEN Xv
	HUANG Yanxia
	DONF Xingyue
	ZHANG Dongliang

Cite this article:

CHEN Yitian,CHEN Xv,HUANG Yanxia等. Preliminary evaluation of physicochemical properties and biological effects of heparinized HA-TCP gelatin scaffold loaded with VEGF[J]. Med. J. Chin. Peop. Armed Poli. Forc., 2022, 33(9): 769-773.

URL:

http://journal08.magtechjournal.com/Jwk_wjyx/EN/ OR http://journal08.magtechjournal.com/Jwk_wjyx/EN/Y2022/V33/I9/769

[1]	Karalashvili L, Kakabadze A, Uhryn M, et al. Bone grafts for reconstruction of bone defects [J]. Georgian Med News, 2018(282):44-49.
[2]	Solakoglu Ö, Götz W, Heydecke G, et al. Histological and immunohistochemical comparison of two different allogeneic bone grafting materials for alveolar ridge reconstruction: a prospective randomized trial in humans[J]. Clin Implant Dent R, 2019, 21(5): 1002-1016.
[3]	Weigand A, Beier J P, Hess A, et al. Acceleration of vascularized bone tissue-engineered constructs in a large animal model combining intrinsic and extrinsic vascularization [J]. Tissue Eng Part A, 2015, 21(9-10): 1680-1694.
[4]	胡越涵, 宋庆高. 牙槽突裂修复手术的研究进展[J]. 组织工程与重建外科杂志, 2019, 15(6):439-442.
[5]	毕浩然, 罗雅馨, 陈晓旭, 等. 细胞支架复合体在牙周软组织增量中的特点及效果[J]. 中国组织工程研究, 2021, 25(16): 2582-2588.
[6]	Logie J, Owen S, Laughlin C, et al. PEG-Graft density controls polymeric nanoparticle micelle stability [J]. Chem Mater. 2014, 26(9):2847-2855.
[7]	Kumar M L, Rather H, Kedaria D, et al. Polymeric microgels for bone tissue engineering applications-a review [J]. Int J Polym Mater Poly, 2020, 69(6): 381-397.
[8]	Bose S, Vahabzadeh S, Bandyopadhyay A. Bone tissue engineering using 3D printing [J]. Mater Today,2013, 16(12):496-504.
[9]	Wang Y, Wan C, Deng L, et al. The hypoxia-inducible factor alpha pathway couples angiogenesis to osteogenesis during skeletal development [J]. J Clin Invest. 2007,117(6):1616-1626.
[10]	Hu K, Olsen B R. The roles of vascular endothelial growth factor in bone repair and regeneration [J]. Bone. 2016, 91:30-38
[11]	Xie A W, Murphy W L. Engineered biomaterials to mitigate growth factor cost in cell biomanufacturing [J]. Curr Opin Biomed Eng, 2019, 10: 1-10.
[12]	Xu X, Jha A, Duncan R, et al. Heparin-decorated, hyaluronic acid-based hydrogel particles for the controlled release of bone morphogenetic protein 2 [J]. Acta biomaterialia. 2011, 7:3050-3059.
[13]	Davies N, Dobner S, Bezuidenhout D, et al. The dosagedependence of VEGF stimulation on scaffold neovascularisation [J]. Biomaterials. 2008, 29(26):3531-3538.
[14]	Li G, Corsi-Payne K, Zheng B, et al. The dose of growth factors influences the synergistic effect of vascular endothelial growth factor on bone morphogenetic protein 4-induced ectopic bone formation [J]. Tissue Eng (Part A), 2009, 15(8): 2123-2133.
[15]	Chung C C, Lin Y K, Chen Y C, et al. Vascular endothelial growth factor enhances profibrotic activities through modulation of calcium homeostasis in human atrial fibroblasts [J]. Lab Invest, 2020, 100(2): 285-296.
[16]	Aragón J, Feoli S, Irusta S, et al. Composite scaffold obtained by electro-hydrodynamic technique for infection prevention and treatment in bone repair [J]. Int J Pharmaceut, 2019, 557: 162-169.
[17]	Li C, Zhu C, Ren B, et al. Two optimized antimicrobial peptides with therapeutic potential for clinical antibiotic-resistant staphylococcus aureus [J].Eur J Med Chem. 2019, 183:111686.
[18]	Rodriguez T M, Acosta L S, Díaz-Torres L A. Photochemically synthesized heparin-based silver nanoparticles: an antimicrobial activity study[C]//Biosensing and Nanomedicine X. SPIE, 2017, 10352: 118-125.
[19]	Germán R Jiménez-Gastélum, Aguilar-Medina E M, Soto-Sainz E, et al. Antimicrobial Properties of Extracellular Matrix Scaffolds for Tissue Engineering[J]. BioMed Research International, 2019.